查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球尼帕病毒感染检测市场
市场调查报告书
商品编码
1380261

2023-2030 年全球尼帕病毒感染检测市场

Global Nipah Virus Infection Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 225 Pages | 商品交期: 2-3个工作天内

价格

细分市场前景

全球尼帕病毒感染检测市场按检测类型、样本和最终用户进行细分。根据测试类型，市场分为基于 RT PCR 的试剂盒和 ELISA 试剂盒。根据样本，市场分为血清或血浆、唾液和咽拭子、尿液等。此外，依市场细分为医院、研究机构、诊断中心等。

ELISA 试剂盒子部分预计将为全球尼帕病毒感染检测市场做出重大贡献

在检测类型中，ELISA试剂盒子细分市场预计将在全球尼帕病毒感染检测市场中占据相当大的份额。该细分市场的成长归因于 ELISA 测试采用率的增加。由于 ELISA 已被证明是尼帕病毒检测的可行技术，因此有可能扩大该测试在临床和公共卫生环境中的使用。 ELISA等经济有效的诊断技术可用于大规模的流行病学调查。据美国国立卫生研究院（gov.）2022年9月称，ELISA是一种有效、安全且具有成本效益的诊断工具，可用于大规模流行病学调查中检测尼帕病毒。 IgM 和 IgG ELISA 测试还可以帮助为公共卫生干预措施提供资讯。此外，与美国疾病管制与预防中心 (CDC) 的参考测试相比，开发的抗 NiV IgM 和 IgG ELISA 表现出 99.28% 的特异性和 100% 的灵敏度。抗尼帕 IgM 和 IgG ELISA 检测显示阴性预测值分别为 100%，阳性预测值分别为 90% 和 93.94%，测试准确度为 99.33%。

区域展望

全球尼帕病毒感染检测市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国） 、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。

亚太地区全球尼帕病毒感染检测市场预计将以显着的CAGR成长

在所有地区中，亚太地区预计在预测期内将以可观的CAGR成长。区域成长归因于测试需求的增加。喀拉拉邦报告的病例强调了拥有准确且广泛可用的尼帕病毒诊断程序的重要性。确诊病例后，还需要进行检测、接触者追踪和疫情管理。

据世界卫生组织（WHO）称，2023年10月，自9月12日以来，已检测了387份样本，结果出现6例尼帕病毒感染阳性病例和381例阴性样本。此外，据喀拉拉邦政府称，2023年9月12日至15日期间报告了六起实验室确诊的尼帕病毒感染病例，其中两人死亡。喀拉拉邦科泽科德地区记录的每起确诊病例均涉及年龄在 9 岁至 45 岁之间的男性。

市场参与者展望

服务尼帕病毒感染检测市场的主要公司包括： Creative Biogene、江苏Bioperfectus Technologies Co., Ltd.、Molbio Diagnostics Pvt.。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布）为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023 年 9 月，喀拉拉邦从印度医学研究委员会 (ICMR) 获得了单株抗体，并在该州中心设立了一个行动实验室，以对抗正在爆发的尼帕病毒。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球尼帕病毒感染检测市场中营运的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按测试类型分類的全球尼帕病毒感染测试市场
    • 基于 RT PCR 的试剂盒
    • ELISA 试剂盒
  • 按样本类型分類的全球尼帕病毒感染检测市场
    • 血清或血浆
    • 唾液和咽拭子
    • 尿
    • 其他（脑脊髓液（CSF）、呼吸道分泌物和环境样本）
  • 全球尼帕病毒感染检测市场（按最终用户）
    • 医院
    • 研究机构
    • 诊断中心
    • 其他（非政府组织 (NGO)、紧急应变小组、公共卫生当局）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Creative Biogene.
  • Creative Diagnostics
  • Indian Council of Medical Research-National Institute of Virus
  • Jiangsu Bioperfectus Technologies Co., Ltd
  • Liferiver Bio-Tech Corp.
  • Molbio Diagnostics Pvt. Ltd.
  • MyBioSource
  • Pirbright researchers
  • YouSeq Ltd.
Product Code: OMR2027811

Title: Global Nipah Virus Infection Testing Market Size, Share & Trends Analysis Report by Test (RT PCR Based Kits, and ELISA Kits), by Sample (Blood Serum or Plasma, Saliva and Throat Swabs, Urine, and Others), and by End-User (Hospitals, Research Institutions, Diagnostic Centers, and Others),Forecast Period (2023-2030).

Global Nipah virus infection testing market is anticipated to grow at a CAGR of 4.8% during the Forecast Period (2023-2030). The market's growth is attributed to the growing incidence of Nipah virus infection across the globe. NiV can be passed from infected animals (such as pigs or bats) or their bodily fluids to individuals through contact. It involves fluids including blood, urine, and saliva. According to the National Institute of Health, in March 2023, Encephalitis and NiV infection are connected (inflammation of the brain). After exposure and a period lasting from 5 to 14 days, the illness starts with a fever and headache that persist for 3-14 days. Lethargy, disorientation, and confusion may then follow. Within 24-48 hours, these signs and symptoms may progress to a coma. Early in their infections, some individuals may experience respiratory issues, and 50% of those who exhibited severe neurological symptoms additionally had pulmonary symptoms. Transmission of NiV may occur through contact with infected animals such as pigs or bats, or their body fluids (such as saliva, urine, or blood). During the first recorded NiV outbreak, people contracted the virus through close contact with sick pigs. The NiV strain found during that outbreak seemed to have initially spread among bats, then to pigs, and finally to pig populations.

Segmental Outlook

The global Nipah virus infection testing market is segmented on the test type, sample, and end-user. Based on the test type, the market is sub-segmented into RT PCR-based kits, and ELISA Kits. Based on the sample, the market is sub-segmented into blood serum or plasma, saliva and throat swabs, urine, and others. Furthermore, based on the market is sub-segmented into hospitals, research institutions, diagnostic centers, and others.

The ELISA Kits Sub-Segment is Anticipated to Contribute Significantly to the Global Nipah Virus Infection Testing Market

Among the test types, the ELISA Kits sub-segment is expected to hold a considerable share of the global Nipah virus infection testing market. The segmental growth is attributed to the increasing ELISA testing adoption. There is potential for an expansion in the use of the tests in clinical and public health settings as ELISA has proven to be a viable technique for Nipah virus detection. Economical and effective diagnostic technologies such as ELISA can be utilized in large-scale epidemiological investigations. According to the National Institute of Health (gov.), in September 2022, ELISA is an effective, safe, and cost-efficient diagnostic tool that can be used to detect Nipah virus in large-scale epidemiological investigations. IgM and IgG ELISA tests can also help inform public health interventions. Furthermore, in comparison to a reference test from the Centers for Disease Control and Prevention (CDC), US, the developed anti-NiV IgM and IgG ELISAs demonstrated a specificity of 99.28% and a sensitivity of 100%. Anti-Nipah IgM and IgG ELISA assays showed 100% negative predictive value and 90% and 93.94% positive predictive value, respectively, with test accuracy of 99.33%.

Regional Outlook

The global Nipah virus infection testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nipah Virus Infection Testing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing demand for testing. The reported cases in Kerala emphasize the significance it is to having accurate and widely available diagnostic procedures for the Nipah virus. Testing for diagnosis, contact tracing, and epidemic management are all required after cases are confirmed.

According to the World Health Organization (WHO), in October 2023, since 12 September, 387 samples have been tested, resulting in six positive cases of Nipah virus infection and 381 negative samples. Furthermore, six laboratory-confirmed cases of Nipah virus infection, including two fatalities, were reported between September 12 and September 15, 2023, according to the Kerala State Government. Males between the ages of 9 and 45 were involved in every confirmed instance, which was recorded in Kerala's Kozhikode district.

Market Players Outlook

The major companies serving the Nipah virus infection testing market include: Creative Biogene, Jiangsu Bioperfectus Technologies Co., Ltd., Molbio Diagnostics Pvt. Ltd., and YouSeq Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2023, Kerala received monoclonal antibodies from the Indian Council of Medical Research (ICMR) and to combat the ongoing Nipah virus outbreak, a mobile laboratory has been set up at the center of the state.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Nipah virus infection testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 1.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nipah Virus Infection Testing Market by Test Type
    • 4.1.1. RT PCR based kits
    • 4.1.2. ELISA Kits
  • 4.2. Global Nipah Virus Infection Testing Market by Sample Type
    • 4.2.1. Blood Serum or Plasma
    • 4.2.2. Saliva and Throat Swabs
    • 4.2.3. Urine
    • 4.2.4. Others (Cerebrospinal Fluid (CSF), Respiratory Secretions, and Environmental Samples)
  • 4.3. Global Nipah Virus Infection Testing Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Research Institutions
    • 4.3.3. Diagnostic Centers
    • 4.3.4. Others (Non-Governmental Organizations (NGOs), Emergency Response Teams, Public Health Authorities)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Creative Biogene.
  • 6.2. Creative Diagnostics
  • 6.3. Indian Council of Medical Research-National Institute of Virus
  • 6.4. Jiangsu Bioperfectus Technologies Co., Ltd
  • 6.5. Liferiver Bio-Tech Corp.
  • 6.6. Molbio Diagnostics Pvt. Ltd.
  • 6.7. MyBioSource
  • 6.8. Pirbright researchers
  • 6.9. YouSeq Ltd.

LIST OF TABLES

  • 1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY TEST TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY SAMPLE, 2022 VS 2030 (%)
  • 5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. LATIN AMERICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. MIDDLE EAST AND AFRICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)